Introduction
Maturity-onset diabetes of the young (MODY) was distinguished from other types of diabetes mellitus in 1970' (1) . It is clinically characterized by nonketotic diabetes mellitus, a primary defect in the function of the beta cells of the pancreas, an onset before the age of 25 yr (usually in childhood or adolescence), and an autosomal dominant mode of inheritance (2) . MODY seems to be an attractive model for genetic studies because its well-defined mode of autosomal dominant inher-itance with high penetrance, and its early onset age that aids the collection of multigenerational pedigrees (3) . The molecular genetic basis of MODY started in the 1990s (4) (5) (6) , showed that MODY is a heterogenous group of monogenic disorders. To date, Online Mendelian Inheritance in Man (OMIM) has listed MODY1-11 based on implicated genes (Table 1) (7). MODY-related genes that have been most commonly studied are the hepatic nuclear factor 4 alpha (HNF4α) (MODY1), glucokinase (GCK) (MODY2), the hepatic nuclear factor 1 alpha (HNF1α) (MODY3), the insulin promoter factor-1 (IPF1) (MODY4) and the hepatic nuclear factor 1 beta (HNF1β) (MODY5). They account for the majority of MODY cases. For example, around 32%, 52%, 10% and 6% of cases in the UK were due to GCK, HNF1α, HNF4α, and HNF1β, respectively (8) . To adding the heterogeneity of MODY, diverse mutations were reported in each pathogenic gene. For GCK only, more than 600 mutations have been described so far, leading to both hypoglycemia and hyperglycemia (9) . Furthermore, 16-45% of the cases of MODY cannot be sorted into these 11 subtypes, and be named MODY-X. More studied are needed to discover the unknown MODY locus or loci (10) . Population studies revealed that heterogeneity also exists within MODY patients of different ethnic groups (11) . For example, MODY2 (GCK) and MODY3 (HNF-1a) were found to account for more than 80% of cases in a cohort of U.K. Caucasians (12) . However, in Hong Kong Chinese, these two forms of MODY were found to be responsible for a mere 4% and 5%, respectively (13) . Except for the subtype heterogeneity, the mutations of the same MODY subtype that has been reported in different populations are usually different and hard to be confirmed (11) .
To help the overall understanding of MODY-related pathologic mutations, we studied a large Chinese MODY family. We use whole genome scan and candidate gene sequencing to identify the MODY subtype of the family, and to find the related gene mutation.
Materials and Methods

Pedigree assessment
A large Han pedigree in 2012 in Shandong Province, northern China, was identified through a proband with typical MODY features (Fig. 1 ).
The pattern of inheritance within the family is consistent with autosomal-dominant inheritance.
In total, 9 individuals in this three-generation family met MODY diagnostic criteria (14) and showed a broad spectrum of clinical diabetic phenotypes. The other 21 family members are unaffected. This study obtained signed informed consent from 9 affected and 17 unaffected family members or their guardians, and 1000 adult voluntary blood donors. This study was approved by the Ethics Committee of the Institute of Basic Medicine of Shandong Academy of Medical Sciences. 
DNA extraction and sample pooling
Peripheral venous blood samples were collected from 9 MODY patients in the family (2 males and 7 females, age 15-54), 17 unaffected family members (8 males and 9 females, age 7-77) and 1000 apparently healthy blood donors randomly selected from the Blood Center of Shandong province (702 males and 298 females, aged 17-55). Genomic DNA was extracted by a modified phenolchloroform method as described before (15) . The pooled DNA samples of (i) MODY patients in the family (n=9), (ii) unaffected family members (n=17), and (iii) unrelated population controls (n=1000), were obtained by combining equal amounts of DNA from each individual (16) .
Genotyping and statistics
A panel of 400 microsatellite marker loci was genotyped in three pooled DNA samples, using ABI PRISM Linkage Mapping Set MD-10 (ABI). The set has fluorescence-labeled PCR primer pairs for 400 highly polymorphic dinucleotide-repeat microsatellite markers chosen from the Geneth on human genetic linkage map on both autosomal and sex chromosomes, with an average spacing of 10cM (17) . Polymerase Chain Reaction (PCR), electrophoresis and genotyping analysis were as described before (15 
Sequencing and alignment for HNF-1β
Primers for nine exons of HNF-1β (listed in 
Results
Genotyping of 400 microsatellite markers in three pooled DNA samples revealed D17S798 as a positive marker to MODY
Of all the 400 microsatellite marker loci in ABI PRISM Linkage Mapping Set MD-10 (ABI), D17S798 on chromosome 17q11.2 was related with MODY in the family. Allele frequencies for D17S798 were found to differ significantly (P<0.001) between the affected and unaffected family members, the affected and the healthy controls, but not between unaffected family members and the healthy controls (P=0.94) (Fig. 2) . No microsatellite markers on sex chromosomes showed significant differences for frequency between any of the DNA pooling samples, indicating an autosomal dominant inheritance that is one of the MODY criterions. 
The mutation of C77T in exon 1 of HNF-1β gene was associated with MODY5 in the family
Close to D17S798 (17q11.2), there is a known MODY-related gene on 17q12, hepatocyte nuclear factor-1β (HNF-1β). The differences of allele frequencies for the D17S798 mentioned above implicated that the affected family members can be sorted as the MODY5 subtype. A single nucleotide variant (SNV) of C77T in the 5ˊ-terminal non-coding region of exon 1 of HNF-1β was related to MODY5 in the proband by sequencing and alignment analysis (Fig. 3) . 
Discussion
In the current study, allelic frequency of marker D17S798 on chromosome 17q11.2 was found to be related to MODY in the Chinese family. The known MODY-related gene near D17S798 is HNF-1β, implicating the patients in the family were MODY5 subtype. Further sequencing and alignment analysis found that a single nucleotide variant (SNV) of C77T in the 5ˊ-terminal noncoding region of exon 1 of HNF-1β was related to MODY5 in the proband. MODY is an entity of several monogenic disorders, and 11 genes have been associated to different MODY subtypes: MODY1 -HNF4α, MO-DY2-GCK, MODY3-HNF1α, MODY4-PDX1,  MODY5-HNF1β, MODY6-NEUROD1, MO-DY7-KLF11, MODY8-CEL, MODY9-PAX4,  MODY10-INS, MODY11-BLK (7) . MODY-related genes are being found continuingly, eg. MODY12-ABCC8 (19) and MODY13-KCNJ11 (20) . Still, a large part of MODY cases are labeled as "MODYX", which means their genetic factors remain unclear and wait to be found. Another research interest in the MODY studies is heterogeneous across populations. The relative prevalence of each subtypes varied (21, 22 (35) and S36F in Chinese patients (30) . A frame-shift mutation, c.C1304del was found in Italy patients, which resulted in a truncated protein (36) . Monoallelic loss of the entire HNF1B gene were reported in Merman patients who showed more severe clinical symptoms other than diabetes, such as pancreas dysplasia, exocrine insufficiency, genital defects and mental retardation (37) . In the systematic review of HNF-1β anomalies related to MODY5 (38) , the detection rate of HNF-1β anomalies was 1.4% among MODY cases (1.4%) and 41.2% among MODY cases with renal structure anomalies. Mutations were strikingly located within the DNA binding domain and spread among exons of the DNA binding domain with exons 2 and 4 were the hottest spots. However, in our MODY family an exon 1 mutation was implicated. This novel SNV is located in the 5ˊ-terminal non-coding region of exon 1. The function of the 5ˊ non-coding region of eukaryotic mRNA and its binding proteins has not been extensively studied. Generally, the 5ˊ non-coding region plays a crucial role in the protein translation by forming secondary structure and providing binding sites for the ribosome and translation factors (39) . Methylation of this region also affects translation (40) . Therefore, we hypothesize that the change from a "methylate-able" base C to a "non-methylate-able" base T in the 5ˊnon-coding region of HNF-1β may change transcription levels by altering the mRNA secondary structure and influence the binding sites for ribosome and/or translation factors.
Conclusion
The SVP of C77T in the 5ˊnon-coding region of HNF-1β was related to MODY5 in the Chinese family studied. Previously detected mutations mainly indicated pathology resulting from the relation between HNF-1β protein structure/function and primary insulin secretory defects. As this novel mutation is in a non-coding region of the gene it suggests that regulation of the gene may be worthy of attention in studying the pathological mechanism of MODY or diabetes.
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